Cynata Therapeutics Ltd
ASX:CYP
Shareholder Yield
Current shareholder yield for 
CYP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CYP Price
Cynata Therapeutics Ltd
| Average Annual Return | -5.75% |
| Standard Deviation of Annual Returns | 73.2% |
| Max Drawdown | -84% |
| Market Capitalization | 84.7m AUD |
| Shares Outstanding | 237 450 000 |
| Percentage of Shares Shorted |
N/A
|
CYP Return Decomposition
Main factors of price return
Stock Splits
CYP's latest stock split occurred on Dec 15, 2020
The company executed a 336-for-335 stock split, meaning that for every 335 shares held, investors received 336 new shares.
Before the split, CYP traded at 0.7328 per share. Afterward, the share price was about 0.71.
The adjusted shares began trading on Dec 15, 2020. This was CYP's 4th stock split, following the previous one in Oct 31, 2013.
